文献速递中医骨伤中药与中成药合理使用

独活寄生汤双靶点抑制COX-2/5-LOX治疗骨关节炎机制研究

Systematic insight into the dual COX-2/5-LOX inhibitory mechanism of Duhuo Jisheng decoction for treatment of osteoarthritis based on in silico and bioassay.
PubMed 文献 · J Ethnopharmacol · 2024-12-17

本研究结合计算机虚拟筛选与酶学、细胞及动物实验,从含1495个化合物的独活寄生汤中筛选出13个候选成分,其中7,4'-二甲氧基异黄酮、染料木素和秦皮乙素可双抑制COX-2与5-LOX,减少炎症因子并保护软骨,且胃肠安全性优于吲哚美辛。

要点

  • 独活寄生汤中7,4'-二甲氧基异黄酮、染料木素和秦皮乙素具有COX-2/5-LOX双重抑制活性。
  • 上述成分可抑制IL-1β诱导软骨细胞PGE2、LTB4、TNF-α、IL-6或NO产生,并减少胶原II降解和MMP-13表达。
  • 角叉菜胶足肿胀模型中3小时水肿抑制率分别为50.00%、56.00%和51.00%,胃溃疡安全性优于吲哚美辛。

核心结论

  • 独活寄生汤中7,4'-二甲氧基异黄酮、染料木素和秦皮乙素具有良好抗炎效果且无胃溃疡作用,有助于解释该方治疗骨关节炎的双重作用机制和潜在物质基础。

研究设计与样本

  • 研究采用分子对接虚拟筛选从独活寄生汤1495个化合物中筛选候选成分,并用酶学实验验证COX-2和5-LOX抑制活性。
  • 体外用IL-1β(10 ng/mL)处理大鼠软骨细胞24小时建立骨关节炎模型,采用CCK-8、ELISA和免疫荧光评估细胞活力、炎症因子及胶原II和MMP-13表达。
  • 建立大鼠软骨外植体培养模型,用番红O和HE染色评估软骨基质降解和软骨损伤。
  • 体内采用角叉菜胶诱导足肿胀实验检测抗炎活性,并进一步检测胃溃疡效应。
  • 最后采用分子动力学模拟和结合自由能分析探讨结合机制。

主要发现

  • 虚拟筛选从独活寄生汤中鉴定出13个候选化合物,其中7,4'-二甲氧基异黄酮、染料木素和秦皮乙素显示对COX-2和5-LOX的双重抑制。
  • 三种化合物可抑制IL-1β诱导的软骨细胞PGE2、LTB4、TNF-α、IL-6或NO产生。
  • 三种化合物减少IL-1β诱导的大鼠软骨细胞胶原II降解和MMP-13表达。
  • 角叉菜胶足肿胀实验中,三种化合物在3小时后的水肿抑制率分别为50.00%、56.00%和51.00%。
  • 三种化合物具有与吲哚美辛相当的优越胃安全性,分子动力学模拟显示其与COX-2和5-LOX结合良好。

关键数值与推荐

  • 独活寄生汤含1495个化合物,虚拟筛选鉴定13个候选化合物,其中3个命中化合物显示COX-2/5-LOX双重抑制。
  • 体外IL-1β诱导软骨细胞模型使用10 ng/mL IL-1β处理24小时。
  • 角叉菜胶足肿胀实验中3小时水肿抑制率分别为50.00%、56.00%和51.00%。

临床怎么用

  • 独活寄生汤治疗骨关节炎可能通过7,4'-二甲氧基异黄酮、染料木素和秦皮乙素等成分双抑制COX-2和5-LOX发挥抗炎作用。
  • 上述成分在临床前研究中显示减少炎症因子和软骨基质降解,且胃肠安全性优于吲哚美辛,为独活寄生汤临床应用提供证据支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Traditional Chinese medicine (TCM) is frequently used to treat osteoarthritis (OA). Duhuo Jisheng decoction (DHJSD), a Chinese patent medicine, was commonly used Chinese herbal formula for the treatment of OA. In Western medicine, dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) enzyme has been proved to be a promising strategy to treat inflammatory diseases with reduced side effects. AIM OF THE STUDY: To elucidate the dual action mechanism of DHJSD targeting COX-2 and 5-LOX against OA. MATERIALS AND METHODS: DHJSD, containing 1495 compounds was screened using a virtual screening approach based on molecular docking. The inhibitory effect of hit compounds against COX-2 and 5-LOX was validated using enzyme-based assays. In vitro, rat chondrocytes were treated with IL-1β (10 ng/mL) for 24 h to induce OA model in vitro. The chondrocyte viability was evaluated using an CCK-8 assay. ELISA was used to detect inflammatory factors expression. Immunofluorescence was used to assess the expression level of collagen II and MMP-13. In addition, a rat cartilage explants culture model was established, and safranin O and HE staining analysis were carried to assess cartilage matrix degradation and cartilage damage, respectively. In vivo, carrageenan-induced paw edema assay was used to examine anti-inflammatory activity, and the gastric ulcerogenic effect was further detected. Finally, Molecular dynamics simulations and binding free energy analysis were carried to explore the binding mechanism. RESULTS: 13 compounds from DHJSD were identified as promising candidates by a virtual screening approach. Among these candidates, three hits 7,4'-dimethoxyisoflavone, genistein, and fraxetin displayed dual inhibition of COX-2 and 5-LOX. Further in vitro assay indicated that 7,4'-dimethoxyisoflavone, genistein, and fraxetin could inhibit PGE2, LTB4, TNF-α, IL-6, or NO production in IL-1β-induced chondrocytes. In addition, the three compounds reduced IL-1β-induced degradation of collagen II and expression of MMP-13 in rat chondrocytes. The results of anti-inflammatory activity of the three compounds in vivo showed that the highest anti-inflammatory activity with edema inhibition percentages of 50.00%, 56.00%, and 51.00% after 3 h, respectively. Moreover, it was found that 7,4'-dimethoxyisoflavone, genistein, and fraxetin have a superior gastric safety profile comparable to indomethacin. Finally, molecular dynamics simulations, binding free energy analysis, and detailed interaction mode demonstrated that 7,4'-dimethoxyisoflavone, genistein, and fraxetin interacted well with both COX-2 and 5-LOX. CONCLUSIONS: 7,4'-dimethoxyisoflavone, genistein, and fraxetin from DHJSD with excellent anti-inflammatory effects and no gastric ulceration effects, which helps to explain the dual action mechanism and potential material basis of DHJSD in treating OA and provide evidence to support DHJSD's clinical use.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Zhang M, Li Y, Liu H, et al. Systematic insight into the dual COX-2/5-LOX inhibitory mechanism of Duhuo Jisheng decoction for treatment of osteoarthritis based on in silico and bioassay. J Ethnopharmacol. 2024. PMID: 39701217. doi:10.1016/j.jep.2024.119263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。